Had a great #AANAM2026. while I was not involved in most of these, I have to brag about Creighton University School of Medicine students Chloe Cohan and Mawj Alzakar, both of whom had abstracts, and BNI resident Vishnu Dantu and fellow Maria Garcia-Dominguez who each had neuroimmunology abstracts.

#AANAM2026 non-inferiority study of fenebrutinib vs ocrelizumab in PPMS. fenebrutinib is non-inferior to ocrelizumab BUT the inactive PPMS population differs from the original ORATORIO trial, so non-inferior to what? I don't have great confidence in ocrelizumab's efficacy in this population.

#AANAM2026 ocrelizumab vs placebo in older and more disabled PPMS patients: delayed disability progression in EDSS and 9 hole peg. Better in younger, Active MS, and More disabled subgroups.

Exciting results in the clinical trial Plenary at #AANAM2026. the first positive phase 3 trial in MOGAD! satralizumab significantly reduced relapse rates in relapsing MOGAD compared to placebo with stable baseline open label immunosuppression allowed. IVSM use & MRI also favored satralizumab.

Exciting results in the clinical trial Plenary at #AANAM2026. First, phase 2 trial on neuro protection in acute optic neuritis. Privosegtor 3mg/kg dosed within 12 days of symptoms WITH concurrent IVSM showed benefit in low contrast visual acuity and OCT. notably aqp4+ excluded.

#AAN2026 #neurosky Today's presidential plenary session. Consistent examples of the importance of basic science translation in neurology. From understanding the role of nuclear porins in sporadic ALS studying childhood genetic disorders. The future of translational neurologic science is bright!

#AANAM #neurosky On future physician shortages: US physician workforce is expected to be at only 88% of need in 2038, Neurology is expected to be fully staffed at 104%. The room of neurologists disagreed. Do we have enough neurologists in the training pathway? bhw.hrsa.gov/sites/defaul...

Newest publication out from several of the outstanding trainees at Barrow Neurology: necrotizing granulomatous encephalitis after endovascular therapy. Congratulations Drs Kaneko, Khanna, and Malaty! doi.org/10.1212/WNL....

Day 3 of #ECTRIMS2025 extension results for ravulizumab in NMO disease (AQP4+). 0 relapses in 105 patient years! absolutely incredible efficacy!

Our abstract on High Efficacy Therapy Use by race/ethnicity. We found that while non-White individuals had higher rates of HET use, the association disappeared when adjusted for disability implying that clinical factors drive prescription patterns. # ECTRIMS2025

#ECTRIMS2025. only 50% of MS patients are up to date vaccines. Inactivated vaccines are NOT associated with relapses and are safe to take in MS. Vaccines are a safe way to reduce infection risk on DMTs. live vaccines may be contraindicated on tx but Can be given 4 weeks before DMT initiation.

Imaging in chronic inflammation session at #ECTRIMS2025 was quite interesting. Several abstracts looking at associations between choroid plexus size and PIRA and chronic active MS lesions. A future easily accessible progressive MS biomarker? #multiplesclerosis

eposter up and available at #ECTRIMS2025. HTN awareness is lower in Hispanic people with MS than the general population and lower than a recent predominantly White MS cohort. younger age is associated with worse awareness, but integrated healthcare is associated with better awareness.

P113 American Heart Association Blood Pressure Categories Have Stronger Associations with Worsening Disability than other Hypertension Metrics In Multiple Sclerosis. - AHA stage II HTN may be a better tool than SBP or DBP alone for future MS HTN comorbidity research Come visit!

2025 NMO criteria. Lots of nomenclature updates but the core is still what we already knew...

#ECTRIMS2025 Lots of diagnostic updates on day 1! 2024 McDonald criteria re-released in conjunction with the lancet papers last week. Reaffirming most of the major changes and attempting to provide better algorithms. Heads up the online PDF had errors last week. Re-download now if you got it before.

Looking Forward to a wonderful three days of scientific discussion around improving the care of MS! #ECTRIMS2025

fear of falling and objectively slower reactive stepping are associated with each other in people with MS, especially in those with a history of falls. Thanks Dan Peterson for inviting me to collaborate. I look forward to working with you in the future. www.sciencedirect.com/science/arti...

I haven't had a chance to post this, but I had the opportunity to discuss our research on Hypertension Awareness with neurology live at CMSC. check out this short highlight! Hypertension Awareness Gaps in Patients With Multiple Sclerosis: Michael Robers, MD, MS share.google/wTGUzi2pwaX4...

Nice that Barrow was recognized for neurological care, but I'm especially happy to see our #MultipleSclerosis center recognized as a "stand out specialty". rankings.newsweek.com/americas-bes...

www.forbes.com/sites/robert... These changes and loss of access to loans will destroy medical students ability to be full time students. Want to guarantee worse doctors? This is it. Call your representatives and oppose these changes!

here is Maya Jayaram's and my abstract on HTN unawareness in MS. 55% of MS pts with HTN are unaware! Check out: Disparities of Hypertension Awareness in Multiple Sclerosis: Age, Sex, and Severity @ 2025 Annual Meeting of the Consortium of Multiple Sclerosis Centers cmsc.confex.com/cmsc/2025/me...

comorbidities such as hypertension (HTN) are important in #multipleSclerosis care. A Gap in care exists where many people with MS are unaware they have HTN. I look forward to presenting our findings on HTN Unawareness today at #CMSC In the "Disease Management" session (north 122abc from 3-5pm).

#CMSC great tips for energy conservation at the interdisciplinary approach to wellness session. moving high frequency items to arm level storage in the home reduces the number of times people have to bend over or reach over their head both of which take more energy.

at the opening lecture for #CMSC discussing the history and importance of comprehensive MS care. one of the things I enjoy about this conference is the interdisciplinary discussions and networking. looking forward to a great 4 days focused on the care of MS!

Read more at

Great to see our trainees representing their Barrow Neurological Institute education at #AAN2025.

glad to see the bill we advocated for with the National MS Society passed. AZ is now protecting patients from medication formulary changes during a plan year. it's small but one step towards comprehensive #PBM reform, and a reminder that local advocacy works! citizenportal.ai/articles/221...

It's MS awareness month, and Barrow Neurological Institute will be hosting its 3rd annual MS Empowerment Summit on April 19th. This summit is for people living with MS as well as their family, friends, and support systems. This years topics will be "MS in the workplace" as well as fatigue management

Happy to wake up early to be a part of #WalkMS Tucson, supporting the NMSS and people affected by MS in Southern AZ. Barrow Neuroimmunology takes care of many people from across Arizona. Our first year at this event is one step we're taking to Broaden our community engagement beyond Phoenix.

Interesting pathology talk by Kevin O'Connor at #ACTRIMS. strong laboratory evidence that MOG antibodies are indeed pathogenic in #MOGAD with compliment and NK cell mediated cell destruction. Implications for future clinical research.

I'm attending The 10th anniversary #ACTRIMS. I attended as a part of the resident summit in the 2nd year. Now as faculty, I'm supporting the Barrow neuroimmunology fellow Rachna Khanna who is presenting and learning here. Happy to now to be a part of training the future of MS specialists.

Pharmacy benefit managers need to be regulated or more honestly eliminated. Awful outcomes occur when profits are put before patients. www.yahoo.com/news/wiscons...

Our new CASPR2 paper is out in Annals Neurology 🤩 Headlines: Patients have neuropathic pain & fatigue as their main long term complaints which determine QoL. 😰 These are NOT immunotherapy responsive. 👩🏾‍⚕️💊 We also report other nuggets in this thread 🧵 ⬇️ onlinelibrary.wiley.com/doi/10.1002/...

Robert F. Kennedy Jr.'s contentious confirmation hearings this week demonstrate why the Trump nominee is unqualified to lead a major federal health agency, according to public health experts. Check out coverage from The Nation's Health, APHA's newspaper: publichealthnewswire.org?p=kennedy-un...

Today I advocated with the Arizona chapter of the National MS Society for state legislation which will prevent Insurance from forcing medication changes without physician and patient consent during a plan year or while a patient is on a continuous insurance policy. Local policy matters in healthcare

#neuroskye & #neuroskyence educators. Thinking about teaching the new Multiple Sclerosis diagnostic criteria to new learners (med students and pgy2s) that don't know the old criteria? I think I have an answer to the gap. Many threads exist about the CHANGES, here is one not referencing 2017.

New here, just an intro. I'm a full time clinical neuroimmunologist, and neurology educator, and a part time clinical researcher. Interested in interact with people with more and less experience with these things so we can all support life long learning:)